Johnson & Johnson
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $22,520,000 | $22,471,000 | $22,447,000 | $21,383,000 |
Gross Profit | 15,392,000 | 15,508,000 | 15,578,000 | 14,872,000 |
EBITDA | 5,484,000 | 8,476,000 | 8,648,000 | |
EBIT | 3,638,000 | 6,694,000 | 6,833,000 | |
Net Income | 3,431,000 | 2,694,000 | 4,686,000 | 3,255,000 |
Net Change In Cash | 22,520,000 | 22,471,000 | 22,447,000 | 21,383,000 |
Free Cash Flow | 4,838,000 | 5,714,000 | 4,657,000 | 2,850,000 |
Cash | 24,105,000 | 19,980,000 | 24,878,000 | 25,473,000 |
Basic Shares | 2,406,922 | 2,427,900 | 2,422,000 | 2,430,100 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $61,350,000 | $85,159,000 | $79,990,000 | $78,740,000 |
Gross Profit | 61,350,000 | 58,413,000 | 55,394,000 | 55,338,000 |
EBITDA | 14,066,000 | 29,339,000 | 27,170,000 | 30,925,000 |
EBIT | 21,853,000 | 20,200,000 | 23,535,000 | |
Net Income | 14,066,000 | 35,153,000 | 17,941,000 | 20,878,000 |
Net Change In Cash | 61,350,000 | 85,159,000 | 79,990,000 | 78,740,000 |
Cost of Revenue | -48,000 | 680,000 | ||
Free Cash Flow | 19,842,000 | 18,248,000 | 17,185,000 | 19,758,000 |
Cash | 1,100 | 21,859,000 | 12,889,000 | 14,487,000 |
Basic Shares | 2,429,400 | 2,560,400 | 2,663,900 | 2,674,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $2.04 |
2024-09-30 | $2.42 |
2024-06-30 | $2.82 |
2024-03-31 | $2.71 |
